Literature DB >> 33680512

Cardiovascular Risk Factor Profiles and Disease in Black Compared to Other Africans with Chronic Kidney Disease.

Hon-Chun Hsu1,2, Chanel Robinson1, Angela J Woodiwiss1, Gavin R Norton1, Patrick H Dessein1,2,3,4.   

Abstract

METHODS: Cardiovascular risk factors, aortic and cardiac function, atherosclerosis extent, and cardiovascular event rates were assessed in 115 consecutive predialysis (n = 67) and dialysis patients (n = 48) including 46 black and 69 other (32 Asian, 28 white, and 9 mixed race) participants. Data were analysed in multivariable regression models.
RESULTS: Overall, black compared to other African CKD patients had less frequent carotid artery plaque (OR (95% CI) = 0.38 (0.16-0.91)) despite an increased cardiovascular risk factor burden. In receiver operator characteristic curve analysis, the Framingham score performed well in identifying non-black but not black CKD patients with carotid plaque (area under the curve (AUC) (95% CI) = 0.818 (0.714-0.921) and AUC (95% CI) = 0.556 (0.375-0.921), respectively). Black compared to other African predialysis patients experienced larger Framingham scores and more adverse nontraditional cardiovascular risk factors, impaired arterial and diastolic function but similar cardiovascular event rates (OR (95% CI) = 0.93 (0.22 to 3.87)). Among dialysis patients, black compared to other Africans had an overall similar traditional and nontraditional cardiovascular risk factor burden, similar arterial and diastolic function but increased systolic function (partial R = 0.356, p = 0.01 and partial R = 0.315, p = 0.03 for ejection fraction and stroke volume, respectively) and reduced cardiovascular event rates (OR (95% CI) = 0.22 (0.05 to 0.88)).
CONCLUSION: Black compared to other African CKD patients have less frequent very high risk atherosclerosis and experience weaker cardiovascular risk factor-atherosclerotic CVD relationships. These disparities may be due to differences in epidemiological health transition stages. Among dialysis patients, black compared to other Africans have less cardiovascular events, which may represent a selection bias as previously documented in black Americans.
Copyright © 2021 Hon-Chun Hsu et al.

Entities:  

Year:  2021        PMID: 33680512      PMCID: PMC7929676          DOI: 10.1155/2021/8876363

Source DB:  PubMed          Journal:  Int J Nephrol


  32 in total

Review 1.  Arterial stiffness and pulse pressure in CKD and ESRD.

Authors:  Marie Briet; Pierre Boutouyrie; Stéphane Laurent; Gérard M London
Journal:  Kidney Int       Date:  2012-08       Impact factor: 10.612

2.  Markers of vascular disease do not differ in black and white hemodialysis patients despite a different risk profile.

Authors:  A Bellasi; E Veledar; E Ferramosca; C Ratti; G Block; P Raggi
Journal:  Atherosclerosis       Date:  2007-05-24       Impact factor: 5.162

3.  Arterial wave reflection and subclinical atherosclerosis in rheumatoid arthritis.

Authors:  Sule Gunter; Chanel Robinson; Angela J Woodiwiss; Gavin R Norton; Hon-Chun Hsu; Ahmed Solomon; Linda Tsang; Aletta M E Millen; Patrick H Dessein
Journal:  Clin Exp Rheumatol       Date:  2017-11-28       Impact factor: 4.473

4.  Effect of diabetes and hypertension on left ventricular diastolic function in a high-risk population without evidence of heart disease.

Authors:  Cesare Russo; Zhezhen Jin; Shunichi Homma; Tatjana Rundek; Mitchell S V Elkind; Ralph L Sacco; Marco R Di Tullio
Journal:  Eur J Heart Fail       Date:  2010-03-07       Impact factor: 15.534

5.  Adiponectin and atherosclerosis risk factors in African hemodialysis patients: a population at low risk for atherosclerotic cardiovascular disease.

Authors:  Oluwatoyin C Amira; Saraladevi Naicker; Pravin Manga; Karen Sliwa; Alamgir Mia; Frederick Raal; Nigel John Crowther; Ronald A Immelman; Steve Olorunju
Journal:  Hemodial Int       Date:  2012-01       Impact factor: 1.812

6.  General cardiovascular risk profile for use in primary care: the Framingham Heart Study.

Authors:  Ralph B D'Agostino; Ramachandran S Vasan; Michael J Pencina; Philip A Wolf; Mark Cobain; Joseph M Massaro; William B Kannel
Journal:  Circulation       Date:  2008-01-22       Impact factor: 29.690

Review 7.  Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review.

Authors:  Mark J Sarnak; Kerstin Amann; Sripal Bangalore; João L Cavalcante; David M Charytan; Jonathan C Craig; John S Gill; Mark A Hlatky; Alan G Jardine; Ulf Landmesser; L Kristin Newby; Charles A Herzog; Michael Cheung; David C Wheeler; Wolfgang C Winkelmayer; Thomas H Marwick
Journal:  J Am Coll Cardiol       Date:  2019-10-08       Impact factor: 24.094

Review 8.  Cardiovascular disease risk amongst African black patients with rheumatoid arthritis: the need for population specific stratification.

Authors:  Ahmed Solomon; Linda Tsang; Angela J Woodiwiss; Aletta M E Millen; Gavin R Norton; Patrick H Dessein
Journal:  Biomed Res Int       Date:  2014-07-23       Impact factor: 3.411

9.  The Impact of Different Classification Criteria Sets on the Estimated Prevalence and Associated Risk Factors of Diastolic Dysfunction in Rheumatoid Arthritis.

Authors:  Lebogang Mokotedi; Sulé Gunter; Chanel Robinson; Gavin R Norton; Angela J Woodiwiss; Linda Tsang; Patrick H Dessein; Aletta M E Millen
Journal:  Int J Rheumatol       Date:  2017-12-04

Review 10.  Cardiovascular disease in dialysis patients.

Authors:  Mario Cozzolino; Michela Mangano; Andrea Stucchi; Paola Ciceri; Ferruccio Conte; Andrea Galassi
Journal:  Nephrol Dial Transplant       Date:  2018-10-01       Impact factor: 5.992

View more
  2 in total

1.  Aortic Stiffness and Pulsatile Pressures as Potential Mediators of Chronic Kidney Disease Induced Impaired Diastolic Function.

Authors:  Hon-Chun Hsu; Grace Tade; Gavin R Norton; Ferande Peters; Chanel Robinson; Noluntu Dlongolo; Gloria Teckie; Angela J Woodiwiss; Patrick H Dessein
Journal:  Int J Nephrol Renovasc Dis       Date:  2022-02-15

2.  Management of Cardiovascular Disease Risk in Rheumatoid Arthritis.

Authors:  Patrick H Dessein; Miguel A Gonzalez-Gay
Journal:  J Clin Med       Date:  2022-06-17       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.